Does Japanese Health Insurance Cover Stem Cell Therapy for Foreign Patients?

If you are going to Japan mainly to receive private stem cell therapy, plan on paying for it yourself. Tourists and most medical tourists are not covered by Japanese public health insurance. Foreign residents and employees may be covered, but only when they are properly enrolled and the treatment itself qualifies for insurance.

For patients comparing hospitals or treatment plans, the practical question is not whether “Japan has stem cell insurance coverage.” What matters is whether your insurance status, your diagnosis, the exact treatment and the hospital all meet the rules at the same time.

Start With Your Insurance Status

Your situation	Japanese public insurance	What you should expect
Tourist visiting Japan	Usually not eligible	Pay the full medical bill yourself or use private/travel insurance
Traveling to Japan specifically for planned stem cell treatment	Usually not eligible	Usually self-pay
Staying in Japan under a designated activity for medical treatment	Generally excluded from National Health Insurance under the applicable rules	Usually self-pay or private insurance
Foreign employee enrolled through a Japanese workplace	Eligible	Insurance can apply to covered medical care
Eligible foreign resident enrolled in National Health Insurance	Eligible	Insurance can apply to covered medical care
Insured resident choosing a private regenerative medicine procedure	You remain insured, but the procedure may be outside insurance	The stem cell procedure may still be 100% self-pay

Japan Pension Service states that workers at covered workplaces are generally enrolled in Employees’ Health Insurance regardless of nationality.^[1] In other words, being foreign does not by itself block access to public insurance.

The situation is different for people entering or staying in Japan specifically for medical treatment. National Health Insurance rules exclude certain foreign nationals staying under designated activities for medical treatment, as well as certain accompanying carers.^[2]

Insurance Only Works When All Four Conditions Match

Requirement	What to confirm
You are insured	You are currently enrolled in Employees’ Health Insurance, National Health Insurance or another applicable Japanese public plan
The treatment is covered	The exact medical product, procedure or service can be billed through public insurance
Your diagnosis qualifies	Your disease, severity and other clinical conditions match the covered indication
The provider qualifies	The hospital and physician meet any requirements for providing and billing the treatment

If one of these four conditions is missing, the stem cell treatment may still be self-pay even if you have a Japanese health insurance card.

When speaking with a hospital, ask the billing department directly:

“Will this exact treatment for my diagnosis be billed through Japanese public health insurance?”

What You May Have to Pay

For treatment that is actually covered by Japanese public insurance, the patient’s share depends on age, income and the applicable insurance rules.

MHLW lists the standard medical copayment as 30% from school age through age 69, with different rates applying to younger children and older patients. Higher-income older patients can also face higher copayment rates.^[6]

Example	Possible patient payment
¥1,000,000 of eligible insured care with a 30% copayment	Initial share: ¥300,000 before any applicable high-cost protection
¥2,000,000 private stem cell procedure	Potentially the full ¥2,000,000
¥3,000,000 private treatment package	Potentially the full ¥3,000,000 plus excluded costs

The 30% rate applies to eligible insured medical fees. It does not turn a private regenerative medicine bill into an insured bill.

High-Cost Medical Benefits Do Not Cover Every Expensive Treatment

Only eligible insurance-covered expenses can qualify.

From August 2026, Japan revised the High-Cost Medical Expense Benefit System and introduced an annual limit. MHLW gives an example in which a person under age 70 with annual income of approximately ¥3.7 million to ¥5.1 million receives ¥1,000,000 of covered medical care and has an eligible out-of-pocket amount of approximately ¥93,000 under the example calculation.^[7]

Expense	High-cost protection
Eligible hospital treatment covered by public insurance	May qualify
Private stem cell procedure outside public insurance	Does not qualify simply because the bill is expensive
Travel, hotel or interpreter fees	Generally outside this medical insurance benefit

A private ¥2,000,000 or ¥3,000,000 cell-treatment bill does not become eligible for this benefit just because the amount is high.

Different Stem Cell Treatments Have Different Insurance Status

Type of treatment	Typical insurance position
Bone marrow transplantation	Can be covered when medically indicated and provided under insurance rules
Peripheral blood stem cell transplantation	Can be covered when medically indicated and provided under insurance rules
Cord blood transplantation	Can be covered when medically indicated and provided under insurance rules
PMDA-approved regenerative medical product	Approval alone is not enough; check the approved indication and whether the specific use is reimbursed
Private cultured autologous cell treatment	Often self-pay
Clinical trial	Payment depends on the trial protocol, sponsor and patient’s insurance status
Officially designated Advanced Medical Care	The advanced technology fee is generally self-pay; qualifying ordinary medical care may remain insured

Japan’s medical fee system contains specific reimbursement items for hematopoietic stem cell collection and transplantation.^[3]

That puts procedures such as bone marrow transplantation in a very different category from private cultured-cell treatment sold by a regenerative medicine clinic. Both may be described as “stem cell treatment,” but the payment rules are not the same.

Do Not Rely on the Word “Approved”

What the clinic says	What you should ask for
“Approved in Japan”	Exact product name, manufacturer, approved indication and current approval status
“PMDA-approved”	PMDA product information or review report for the exact product
“Registered with MHLW”	Ask whether this refers to a regenerative medicine provision plan or an approved medical product
“Provided under Japanese regenerative medicine law”	Ask which legal pathway applies and whether treatment is public-insurance covered or self-pay
“Insurance is available”	Written confirmation that your exact treatment and diagnosis can be billed through Japanese public insurance

Medical institutions providing regenerative medicine under the Act on the Safety of Regenerative Medicine must complete the required procedures before treatment.^[4] Completing those procedures does not automatically mean the treatment is a PMDA-approved product or that public insurance will pay for it.

Check the Exact Product and Disease

If a clinic says it uses an approved regenerative medical product, ask for:

brand name;
generic or non-proprietary name;
manufacturer;
PMDA approval information;
approved disease or indication;
patient eligibility requirements; and
whether the product is reimbursed for your intended use.

TEMCELL HS, for example, is an allogeneic bone-marrow-derived mesenchymal stem cell product. Its Japanese review documents identify its indication as acute graft-versus-host disease following hematopoietic stem cell transplantation.^[5]

That does not mean mesenchymal stem cells are automatically approved or insurance-covered for knee osteoarthritis, chronic pain, Parkinson’s disease or other unrelated conditions.

If a clinic only says “stem cells are approved in Japan,” that is not enough information to decide whether the treatment being offered to you is approved or covered.

Check How Insured and Self-Pay Charges Are Split

A clinic may offer a private stem cell procedure alongside examinations, imaging, medication or hospital care. Do not assume each part can automatically be billed separately under whichever payment method costs less.

Japan restricts combinations of insured and non-insured medical care. Defined exceptions exist, including evaluation treatment, patient-requested treatment and selected treatment.

Under officially designated Advanced Medical Care, the patient pays the advanced medical technology fee in full, while eligible ordinary medical services can remain subject to public insurance rules.^[8]

Before treatment, request a written bill showing:

which services will be billed through public insurance;
which services are fully self-pay;
the estimated amount for each item; and
whether the billing arrangement can change if additional treatment is needed.

Get Private or Travel Insurance Approval Before You Travel

Private and travel insurance policies vary, especially when treatment is planned before the trip. Do not assume a policy that covers emergency hospitalization in Japan will also cover scheduled regenerative medicine.

Ask the insurer:

Is planned stem cell or regenerative treatment in Japan covered?
Is medical tourism excluded?
Are pre-existing conditions excluded?
Is experimental or investigational treatment excluded?
Is prior authorization required?
Are complications from an excluded stem cell procedure covered?
Is follow-up treatment covered?
Will the insurer pay the Japanese hospital directly?
Must I pay the full amount first and request reimbursement later?
What documents must the Japanese clinic provide for a claim?

Get the answer in writing before paying a clinic deposit or booking treatment-related travel.

Do Not Pay Until You Have These Documents

Document	What it should contain
Treatment plan	Diagnosis, cell type, cell source, dose, route, number of administrations and treatment schedule
Regulatory information	The Japanese legal or regulatory pathway used for the treatment
Insurance confirmation	Whether the exact treatment for your diagnosis is public-insurance covered or self-pay
Itemized quotation	Separate prices for all major medical and non-medical services
Cancellation policy	Refund rules before and after cell collection or processing begins
Cell processing information	Processing facility, quality testing and what happens if the cells fail release criteria
Complication-cost policy	Who pays if hospitalization, medication or emergency treatment is required
Follow-up plan	Required visits in Japan and follow-up that can be completed after returning home

For a B2B medical coordinator, hospital or international patient team, these documents also reduce disputes later. The patient can see what is covered, what is private and what happens if treatment changes or cannot proceed.

Ask for a Full Cost Breakdown

A quote that only says “Stem Cell Treatment Package: ¥3,000,000” is not detailed enough.

Request separate prices for:

initial medical consultation;
blood tests;
MRI, CT or other imaging;
cell or tissue collection;
cell isolation;
cell culture or expansion;
quality and release testing;
cell administration;
medication;
hospitalization;
additional treatment sessions;
follow-up appointments;
interpretation;
medical-record translation;
medical certificates;
treatment of adverse events; and
emergency care.

The quotation should also state what happens financially if:

too few cells are collected;
cell culture fails;
quality testing fails;
contamination occurs;
the physician cancels treatment;
your medical condition changes;
treatment is delayed; or
you cannot return to Japan for another administration.

These points matter because the final amount can be very different from the advertised package price once additional testing, repeat visits or complication-related care is added.

Know Who Can Give You a Reliable Answer

Question	Who should answer it
Am I enrolled in Japanese public insurance?	Your insurer, employer or relevant municipal insurance office
Is this treatment medically appropriate?	Treating physician
Can this exact treatment be billed through public insurance?	Hospital billing or insurance department
Is this regenerative medical product approved?	PMDA records
What is the approved indication?	PMDA product information and treating physician
Which regenerative medicine legal pathway applies?	Treating institution and MHLW records
Will my overseas insurer reimburse the treatment?	Your private or travel insurer
How much will I have to pay before treatment?	Hospital or clinic billing department

A sales representative, international coordinator or clinic website can help explain the process, but they should not replace written confirmation from the party responsible for the decision.

Official Sources

Finally

If you are traveling to Japan mainly for private stem cell therapy, budget as if you will pay the full price yourself. Public insurance only helps when you are properly enrolled and the exact treatment, diagnosis and provider qualify. A 30% copayment or the High-Cost Medical Expense Benefit applies to eligible insured care, not automatically to a private ¥2,000,000 or ¥3,000,000 cell procedure. Before paying, get the treatment details, insurance status, full quotation and cancellation terms in writing. Those four documents will tell you far more than a clinic saying the treatment is “approved” or “insurance may apply.”